AIP
DICE

Ameritas Investment Partners’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Ameritas Investment Partners’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,199
Closed -$149K – 3144
2023
Q2 		$149K Buy
3,199
+367
+13% +$12.7K 0.01% 1331
2023
Q1 		$81.1K Hold
2,832
– – ﹤0.01% 1670
2022
Q4 		$86.6K Buy
2,832
+703
+33% +$22.9K ﹤0.01% 1703
2022
Q3 		$43K Hold
2,129
– – ﹤0.01% 2100
2022
Q2 		$33K Buy
2,129
+1,053
+98% +$18.1K ﹤0.01% 2271
2022
Q1 		$21K Hold
1,076
– – ﹤0.01% 2554
2021
Q4 		$27K Buy
+1,076
New +$31.5K ﹤0.01% 2513

Ameritas Investment Partners's DICE Position: Q3 2023 in Review

Ameritas Investment Partners sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 3,199 shares — an estimated $149K sold.

Ameritas Investment Partners first reported a position in DICE in Q4 2021 and held it in 7 quarters. The position peaked at $149K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Ameritas Investment Partners reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Ameritas Investment Partners sold 3,199 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $149K.
  • Ameritas Investment Partners first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • Ameritas Investment Partners's DICE Therapeutics, Inc. Common Stock position peaked at $149K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Ameritas Investment Partners's 13F filing for Q3 2023, filed 13 Nov 2023.